If you made any changes in Pure these will be visible here soon.

Personal profile

Public Profile

Dr Robert Jorissen is a postdoctoral researcher for the ROSA at SAHMRI and a research fellow in the College of Medicine & Public Health, Flinders University. His current work involves analysing ROSA registry data on people who are receiving aged care services (both in home and residential aged care) with respect to occurrences such as falls, fractures and medication use. Robert is passionate about applying data analysis and predictive analytics methodologies to questions whose answers may lead to improvement in patient and population health.

His previous training and experience include a PhD in bioinformatics (University of Melbourne) and a Master of Biostatistics (Monash University). He has previously applied his skills to areas such as molecular epidemiology for colorectal cancer, evaluation of cancer prognosis calculators, statistical and bioinformatics calculations for cancers such as melanoma and lymphoma, structure-activity analysis of lead compounds against HIV protease and protein structure modelling.

Education/Academic qualification

Masters, Monash University

Graduate Diploma, Monash University

PhD, University of Melbourne

Bachelor of Science (Honours), Monash University

External positions

Flinders University

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

  • 4869 Citations
  • 24 h-Index
  • 36 Article
  • 3 Review article
  • 1 Chapter

Evaluation of the transferability of survival calculators for stage II/III colon cancer across healthcare systems

Jorissen, R., Croxford, M., Jones, I. T., Ward, R. L., Hawkins, N. J., Gibbs, P. & Sieber, O. M., 1 Jul 2019, In : International Journal of Cancer. 145, 1, p. 132-142 11 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)

Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes

Williams, D. S., Mouradov, D., Jorissen, R., Newman, M. R., Amini, E., Nickless, D. K., Teague, J. A., Fang, C. G., Palmieri, M., Parsons, M. J., Sakthianandeswaren, A., Li, S., Ward, R. L., Hawkins, N. J., Faragher, I., Jones, I. T., Gibbs, P. & Sieber, O. M., 1 Mar 2019, In : Gut. 68, 3, p. 465-474 10 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

MACROD2 haploinsufficiency impairs catalytic activity of PARP1 and promotes chromosome instability and growth of intestinal tumors

Sakthianandeswaren, A., Parsons, M. J., Mouradov, D., Mackinnon, R. N., Catimel, B., Liu, S., Palmieri, M., Love, C., Jorissen, R., Li, S., Whitehead, L., Putoczki, T. L., Preaudet, A., Tsui, C., Nowell, C. J., Ward, R. L., Hawkins, N. J., Desai, J., Gibbs, P., Ernst, M. & 3 othersStreet, I., Buchert, M. & Sieber, O. M., 1 Aug 2018, In : Cancer Discovery. 8, 8, p. 988-1005 18 p.

Research output: Contribution to journalArticle

36 Citations (Scopus)

BRAF V600E mutant colorectal cancer subtypes based on gene expression

Barras, D., Missiaglia, E., Wirapati, P., Sieber, O. M., Jorissen, R., Love, C., Molloy, P. L., Jones, I. T., McLaughlin, S., Gibbs, P., Guinney, J., Simon, I. M., Roth, A. D., Bosman, F. T., Tejpar, S. & Delorenzi, M., 1 Jan 2017, In : Clinical Cancer Research. 23, 1, p. 104-115 12 p.

Research output: Contribution to journalArticle

10 Citations (Scopus)

Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity

Wang, J., Mouradov, D., Wang, X., Jorissen, R., Chambers, M. C., Zimmerman, L. J., Vasaikar, S., Love, C. G., Li, S., Lowes, K., Leuchowius, K. J., Jousset, H., Weinstock, J., Yau, C., Mariadason, J., Shi, Z., Ban, Y., Chen, X., Coffey, R. J. C., Slebos, R. J. C. & 4 othersBurgess, A. W., Liebler, D. C., Zhang, B. & Sieber, O. M., 1 Oct 2017, In : Gastroenterology. 153, 4, p. 1082-1095 14 p.

Research output: Contribution to journalArticle